CINCINNATI--(BUSINESS WIRE)--Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ:VIVO) today increased its previous guidance for fiscal 2007 earnings from a range of $0.55 to $0.58 per share (as adjusted for the May 11, 2007 three-for-two stock split) to a new range of $0.57 to $0.60 per share. The per share estimates assume an increase in average shares outstanding from approximately 40.2 million at fiscal 2006 year end to 40.5 million at fiscal 2007 year end. Net sales guidance has been increased from the previous range of $118 to $123 million to a new range of $121 to $124 million. The sales and earnings guidance provided in this press release does not include the impact of any acquisitions the Company might complete during fiscal 2007.
